Pilot Efficacy Study of T2000 in Myoclonus Dystonia

Summary

This pilot study will evaluate the safety and efficacy of once daily T2000 when used to treat patients with Myoclonus Dystonia over a 12 week period.

Timeline

Start

2007-08

Primary completion

2011-08

Completion

2011-10

Outcome

Outcome not reported

Stopped (Enrollment): “Slow Recruitment of eligible patients”

Publications

• Background Melmed C, Moros D, Rutman H. Treatment of essential tremor with the barbiturate T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid). Mov Disord. 2007 Apr 15;22(5):723-7. doi: 10.1002/mds.21321.

Drugs

Indications